Pharmacological manipulation of dendritic cells in the pursuit of transplantation tolerance

Current Opinion in Organ Transplantation

Volumn 16, Issue 4, 2011, Pages 372-378

  Leishman, Alison J ^a   Silk, Kathryn M ^a   Fairchild, Paul J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

dendritic cells; pharmacological agents; tolerance

Indexed keywords

B7 ANTIGEN; CALCITRIOL; CD40 LIGAND; CD86 ANTIGEN; CHORIONIC GONADOTROPIN; CURCUMIN; DEXAMETHASONE; ESTRADIOL; GAMMA INTERFERON; IBUPROFEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; MYCOPHENOLIC ACID; PROGESTERONE; RAPAMYCIN; RESVERATROL; SYNAPTOPHYSIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TRANSFORMING GROWTH FACTOR BETA;

ANTIGEN SPECIFICITY; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL MANIPULATION; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; DENDRITIC CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOGENICITY; IMMUNOSUPPRESSIVE TREATMENT; MEMORY T LYMPHOCYTE; NONHUMAN; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE; TRANSPLANTATION TOLERANCE;

ANIMALS; CYTOKINES; DENDRITIC CELLS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; ORGAN TRANSPLANTATION; PHENOTYPE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; TRANSPLANTATION TOLERANCE; TREATMENT OUTCOME;

EID: 80051797905     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e3283484b42     Document Type: Review

References (53)

1. Schwartz R, Dameshek W. Drug-induced immunological tolerance. Nature 1959; 183:1682-1683.
2. Goodwin WE, Mims MM, Maxwell MM, et al. Human renal transplantation. 1: Clinical experiences with 6 cases of renal homotransplantation. J Urol 1963; 89:13-24.
3. Schwartz R, Dameshek W. The effects of 6-mercaptopurine on homograft reactions. J Clin Invest 1960; 39:952-958.
4. Ravindra KV, Wu S, McKinney M, et al. Composite tissue allotransplantation: Current challenges. Transplant Proc 2009; 41:3519-3528.
5. Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. J Exp Med 1973; 137:1142-1162.
6. Hackstein H, Thomson AW. Dendritic cells: Emerging pharmacological targets of immunosuppressive drugs. Nat Rev Immunol 2004; 4:24-34. (Pubitemid 38084129)
7. Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18:767-811. (Pubitemid 30365397)
8. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003; 21:685-711. (Pubitemid 37174545)
9. Dhodapkar MV, Steinman RM, Krasovsky J, et al. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med 2001; 193:233-238. (Pubitemid 32524454)
10. Svajger U, Obermajer N, Jeras M. Dendritic cells treated with resveratrol during differentiation from monocytes gain substantial tolerogenic properties upon activation. Immunol 2010; 129:525-535.
11. Cicinnati VR, Hou J, Lindemann M, et al. Mycophenolic acid impedes the antigen presenting and lymph node homing capacities of human blood myeloid dendritic cells. Transplantation 2009; 88:504-513.
12. Unger WWJ, Laban S, Kleijwegt FS, et al. Induction of Treg by monocytederived DC modulated by vitamin D-3 or dexamethasone: Differential role for PD-L1. Eur J Immunol 2009; 39:3147-3159.
13. Fazekasova H, Golshayan D, Read J, et al. Regulation of rat and human T-Cell immune response by pharmacologically modified dendritic cells. Transplantation 2009; 87:1617-1628.
14. Chamorro S, Garcia-Vallejo JJ, Unger WWJ, et al. TLR triggering on tolerogenic dendritic cells results in TLR2 up-regulation and a reduced proinflammatory immune program. J Immunol 2009; 183:2984-2994.
15. Stoop JN, Harry RA, von Delwig A, et al. Therapeutic effect of tolerogenic dendritic cells in established collagen-induced arthritis is associated with a reduction in Th17 responses. Arthritis Rheum 2010; 62:3656-3665.
16. Rogers NM, Kireta S, Coates PT. Curcumin induces maturation-arrested dendritic cells that expand regulatory T cells in vitro and in vivo. Clin Exp Immunol 2010; 162:460-473.
17. Jones LA, Kreem S, Shweash M, et al. Differential modulation of TLR3-and TLR4-mediated dendritic cell maturation and function by progesterone. J Immunol 2010; 185:4525-4534. Data demonstrating a different effect of progesterone on TLR3-signalling and TLR4-signalling pathways in dendritic cells.
18. Segerer SE, Muller N, van den Brandt J, et al. Impact of female sex hormones on the maturation and function of human dendritic cells. Am J Reprod Immunol 2009; 62:165-173.
19. Bufan B, Mojsilovic S, Vucicevic D, et al. Comparative effects of aspirin and NO-releasing aspirins on differentiation, maturation and function of human monocyte-derived dendritic cells in vitro. Int Immunopharmacol 2009; 9: 910-917.
20. Kim H-J, Lee Y-H, Im S-A, et al. Cyclooxygenase inhibitors, aspirin and ibuprofen, inhibit MHC-restricted antigen presentation in dendritic cells. Immune Network 2010; 10:92-98.
21. Lohr J, Knoechel B, Jiang SW, et al. The inhibitory function of B7 costimulators in T cell responses to foreign and self-antigens. Nature Immunol 2003; 4:664-669. (Pubitemid 36874443)
22. Bar-On L, Birnberg T, Kim K-w, Jung S. Dendritic cell-restricted CD80/86 deficiency results in peripheral regulatory T-cell reduction but is not associated with lymphocyte hyperactivation. Eur J Immunol 2011; 41:291-298.
23. Amarnath S, Costanzo CM, Mariotti J, et al. Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1. PLoS Biol 2010; 8:e1000302. This article provides evidence that human Treg cells are able to drive allogeneic dendritic cells towards a tolerogenic phenotype which suppress CD4+ and CD8+ T-cell proliferation and induce Treg cells in a PD-1-PD-L1-dependent tolerogenic loop.
24. Torres-Aguilar H, Aguilar-Ruiz SR, González-Pérez G, et al. Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells. J Immunol 2010; 184:1765-1775. This study shows that IL-10 and IL-10/TGF-b-treated dendritic cells have tolerogenic properties inducing antigen-specific CD4+ memory T-cell anergy and T cells with suppressive activity on memory T-cell proliferation.
25. Grohmann U, Orabona C, Fallarino F, et al. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat Immunol 2002; 3:1097-1101. (Pubitemid 35363664)
26. Haidinger M, Poglitsch M, Geyeregger R, et al. A versatile role of mammalian target of rapamycin in human dendritic cell function and differentiation. J Immunol 2010; 185:3919-3931. Data presented in this article demonstrate that the effect of mTOR inhibition varies between dendritic cell subsets, as it was shown to enhance the tolerogenic potential in moDCs while promoting the immunogenicity of non-moDCs, findings which may have broader implications for the therapeutic derivation of tDCs.
27. Manavalan JS, Rossi PC, Vlad G, et al. High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells. Transplant Immunol 2003; 11:245-258. (Pubitemid 37120544)
28. Peng YLY, Elkon KB. Ly6C(low) monocyte differentiate into dendritic cells and cross-tolerize T cells through PDL-1. J Immunol 2009; 182:2777-2785.
29. Kim-Schulze S, Scotto L, Vlad G, et al. Recombinant Ig-like transcript 3-Fc modulates T cell responses via induction of Th anergy and differentiation of CD8+ T suppressor cells. J Immunol 2006; 176:2790-2798.
30. Chang CC, Liu ZR, Vlad G, et al. Ig-like transcript 3 regulates expression of proinflammatory cytokines and migration of activated T cells. J Immunol 2009; 182:5208-5216.
31. Min WP, Zhou D, Ichim TE, et al. Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance. J Immunol 2003; 170:1304-1312. (Pubitemid 36139497)
32. Fife BT, Pauken KE, Eagar TN, et al. Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal. Nat Immunol 2009; 10:1185-1192.
33. Luger TA, Schwarz T. The role of cytokines and neuroendocrine hormones in cutaneous immunity and inflammation. Allergy 1995; 50:292-302.
34. Bartels LE, Hvas CL, Agnholt J, et al. Human dendritic cell antigen presentation and chemotaxis are inhibited by intrinsic 25-hydroxy vitamin D activation. Int Immunopharmacol 2010; 10:922-928. These authors provide evidence that intrinsic conversion of 25-hydroxy vitamin D3 into VD3 by human moDCs is able and sufficient to promote tolerogenic properties.
35. Anderson AE, Sayers BL, Haniffa MA, et al. Differential regulation of naive and memory CD4+ T cells by alternatively activated dendritic cells. J Leukocyte Biol 2008; 84:124-133. (Pubitemid 351960287)
36. Harry RA, Anderson AE, Isaacs JD, Hilkens CMU. Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis. Ann Rheum Dis 2010; 69:2042-2050. This study was able to derive stable tDCs from rheumatoid arthritis patients using dexamethasone and VD3 and detected high expression levels of TLR2 on tDCs, suggesting a possible marker of such cells.
37. Manicassamy S, Ravindran R, Deng JS, et al. Toll-like receptor 2-dependent induction of vitamin A-metabolizing enzymes in dendritic cells promotes T regulatory responses and inhibits autoimmunity. Nat Med 2009; 15:401-409.
38. DePaolo RW, Tang FM, Kim I, et al. Toll-like receptor 6 drives differentiation of tolerogenic dendritic cells and contributes to LcrV-mediated plague pathogenesis. Cell Host Microbe 2008; 4:350-361.
39. Pedersen AW, Holmstrom K, Jensen SS, et al. Phenotypic and functional markers for 1 alpha,25-dihydroxyvitamin D-3-modified regulatory dendritic cells. Clin Exp Immunol 2009; 157:48-59.
40. Chang CC, Ciubotariu R, Manavalan JS, et al. Tolerization of dendritic cells by T-S cells: The crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol 2002; 3:237-243. (Pubitemid 34218114)
41. Menges M, Rossner S, Voigtlander C, et al. Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J Exp Med 2002; 195:15-21. (Pubitemid 34074492)
42. Lim DS, Kang MS, Jeong JA, Bae YS. Semi-mature DC are immunogenic and not tolerogenic when inoculated at a high dose in collagen-induced arthritis mice. Eur J Immunol 2009; 39:1334-1343.
43. Anderson AE, Swan DJ, Sayers BL, et al. LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells. J Leukocyte Biol 2009; 85:243-250.
44. Huang YL, Wang YZ, Chen JB, et al. Prevention of acute and chronic allograft rejection by combinations of tolerogenic dendritic cells. Scand J Immunol 2011; 73:91-101.
45. Yamano T, Watanabe S, Hasegawa H, et al. Ex vivo-expanded DCs induce donor-specific central and peripheral tolerance and prolong the acceptance of donor skin grafts. Blood 2011; 117:2640-2648.
46. Gaudreau S, Guindi C, Ménard M, et al. GM-CSF induces bone marrow precursors of NOD mice to skew into tolerogenic dendritic cells that protect against diabetes. Cell Immunol 2010; 265:31-36.
47. Brenk M, Scheler M, Koch S, et al. Tryptophan deprivation induces inhibitory receptors ILT3 and ILT4 on dendritic cells favoring the induction of human CD4+CD25+Foxp3+ T regulatory cells. J Immunol 2009; 183:145-154.
48. Wilson JM, Ross WG, Agbai ON, et al. The A(2B) adenosine receptor impairs the maturation and immunogenicity of dendritic cells. J Immunol 2009; 182: 4616-4623.
49. Eljaafari A, Li YP, Miossec P. IFN-g, as secreted during an alloresponse, induces differentiation of monocytes into tolerogenic dendritic cells, resulting in FoxP3+ regulatory T cell promotion. J Immunol 2009; 183:2932-2945.
50. Fairchild PJ. Transplantation tolerance in an age of induced pluripotency. Curr Opin Organ Transplant 2009; 14:321-325.
51. Choi K-D, Vodyanik MA, Slukvin II. Generation of mature human myelomonocytic cells through expansion and differentiation of pluripotent stem cellderived lin-CD34+CD43+CD45+ progenitors. J Clin Invest 2009; 119: 2818-2829.
52. Choi K-D, Vodyanik M, Slukvin II. Hematopoietic differentiation and production of mature myeloid cells from human pluripotent stem cells. Nat Protocols 2011; 6:296-313.
53. Tseng SY, Nishimoto KP, Silk KM, et al. Generation of immunogenic dendritic cells from human embryonic stem cells without serum and feeder cells. Regen Med 2009; 4:513-526.